GS18-02

Main Content

Impact of racial background on survival following haploidentical donor transplantation with post-transplant cyclophosphamide for adults with hematologic malignancies and comparison with race-specific outcomes following umbilical cord blood transplantation.

Study #: GS18-02

Study Status: Published

Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant.

Citation

Solomon SR, St Martin A, Zhang M-J, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, Peres E, Ringden O, Rizzieri D, Romee R, Solh M, Szwajcer D, van der Poel M, Waller E, William BM, Eapen M.

Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2020, Oct 01: 26(10): 26(10):1930-1936. doi: 10.1016/j.bbmt.2020.06.029. Epub 2020, Jul 07. PMCID:PMC7530013.

PubMed

PMID: 32649981

Abstract